LCB revenue for the last year amounted to 34.05 B KRW, the most of which — 21.34 B KRW — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 20.33 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought LCB 34.15 B KRW, and the year before that — 33.41 B KRW.